Author: usaeverydaylife

Former U.S. President Joe Biden and former First Lady Jill Biden pose for a selfie photo, in this handout social media picture released May 19, 2025. Joe Biden Via X | Joe Biden Via ReutersFormer President Joe Biden is receiving radiation and hormone therapy as part of a new phase of treating the aggressive form of prostate cancer he was diagnosed with after leaving office, a spokesperson said Saturday.”As part of a treatment plan for prostate cancer, President Biden is currently undergoing radiation therapy and hormone treatment,” said Biden aide Kelly Scully.The 82-year-old Democrat left office in January after he…

Read More

Stocks dropped Friday after President Donald Trump threatened higher tariffs on China , but one technical metric reveals that some stocks could be oversold and soon due for a rally. A summer of calm in the stock market was disrupted after Trump threatened to slap a “massive increase of Tariffs” on Chinese imports into the United States. These higher tariffs would counter new controls that China has levied on its rare earth exports. The Dow Jones Industrial Average plunged 879 points, or 1.9%, and ended the week 2.7% lower. The S & P 500 dropped 2.7% on Friday, while the…

Read More

U.S. President Donald Trump looks on during an announcement about lowering U.S. drug prices, at the White House in Washington, D.C., U.S., Oct. 10, 2025. Kent Nishimura | ReutersOn Friday morning, the S&P 500 was less than a couple of points from another all-time high. Then, after a single social media post from President Donald Trump, $2 trillion in market value was wiped out.The unraveling shows the sway the president’s one-man trade policy still has over the fate of the global economy.Trump at 10:57 a.m. ET wrote on his Truth Social platform that China was “becoming very hostile” with the…

Read More

Investors aiming to predict which stocks will pop during earnings season may want to keep an eye on companies that have strong track records of exceeding Wall Street’s expectations. Earnings season for the third quarter starts ramping up next week. Some of the companies slated to share their top- and bottom-line results next week include JPMorgan, Citigroup, Goldman Sachs and Johnson & Johnson. We screened Bespoke Investment Group data for names that have beaten earnings expectations at least 80% of the time, while averaging a gain of at least 1% in the next trading session following results. Here are a…

Read More

Company: Atkore (ATKR)Business: Atkore is a manufacturer of electrical products for construction and renovation markets, and safety and infrastructure products for the construction and industrial markets. The company’s segments include electrical and safety & infrastructure. The electrical segment manufactures products used in the construction of electrical power systems including conduit, cable and installation accessories. This segment serves contractors in partnership with the electrical wholesale channel. The safety & infrastructure segment designs and manufactures solutions including metal framing, mechanical pipe, perimeter security and cable management for the protection and reliability of critical infrastructure. These solutions are marketed to contractors, OEMs, and…

Read More

(This is the Warren Buffett Watch newsletter, news and analysis on all things Warren Buffett and Berkshire Hathaway. You can sign up here to receive it every Friday evening in your inbox.)Berkshire’s Japanese stock positions top $30 billionThe total value of the five Japanese “trading houses” in Berkshire Hathaway’s equity portfolio has topped $30 billion in recent weeks, and Warren Buffett is apparently still buying.Zoom In IconArrows pointing outwardsBerkshire had already been building its positions for twelve months when Buffett initially revealed the stakes of around 5% each on August 30, 2020, his 90th birthday.At that time, the total value of the five positions…

Read More

Alistair Berg | Digitalvision | Getty ImagesWhen it comes to how we approach money, “no one is crazy,” Morgan Housel wrote in his bestselling 2020 book on building wealth, “The Psychology of Money.”And when it comes to the way we spend money, the decisions we make are just as personal, Housel, a partner at Collaborative Fund, writes in his new book, “The Art of Spending Money.””It’s an art because it’s subjective,” Housel told CNBC.com in an interview ahead of the book’s Oct. 7 publication.Those decisions are crucial to building and maintaining wealth, he says: “Wealth is always a two-part equation…

Read More

OpenAI DevDayAshley Capoot | CNBCVirtually every successful tech startup throughout history has faced the reality that it could get swallowed up or run over by a large incumbent at any moment. It’s part of daily life for an entrepreneur.But the company at the center of the current boom is a different kind of beast.Unlike industry giants of past eras, OpenAI is privately held. Its financials are mostly secretive and its ability and willingness to spend other people’s money is unrivaled.And as OpenAI has proven recently, through a dizzying array of mammoth deals and product rollouts, the artificial intelligence lab is…

Read More

FILE PHOTO: Luigi Mangione, the suspect in the killing of UnitedHealth Group chief executive Brian Thompson, appears in Manhattan Supreme Court on New York state murder and terrorism charges in New York City, U.S., February 21, 2025.Curtis Means | Via ReutersLawyers for Luigi Mangione asked a New York federal judge Saturday to dismiss some criminal charges, including the only count for which he could face the death penalty, from a federal indictment brought against him in the December assassination of UnitedHealth’s chief executive.In papers filed in Manhattan federal court, the lawyers said prosecutors should also be prevented from using at…

Read More

People protesting personnel cuts at the Centers for Disease Control (CDC) hold signs outside the organization’s main headquarters on March 12, 2025 in Atlanta, Georgia.Elijah Nouvelage | Getty Images News | Getty ImagesThe Trump administration has laid off dozens of employees at the Centers for Disease Control and Prevention in its latest round of cuts, including “disease detectives,” high-ranking scientists and the entire Washington office, the New York Times reported on Saturday.The White House and the CDC did not immediately respond to Reuters requests for comment.Affected workers were sent layoff notices via email shortly before 9 p.m. ET (0100 GMT)…

Read More